
Gufic Biosciences Ltd. (GUFICBIO): Gufic Biosciences Share Price Hits Fresh 52-Week High on 6.66% Rise
Updated: 2 Sept 2026 • 12:49 pm
Posted by:

Gufic Biosciences Share Price was at Rs 448.45, up 6.66%, and touched a fresh 52-week high of Rs 453, with market capitalisation at Rs 4,162.23 crore. The move keeps Gufic Biosciences Ltd. (GUFICBIO) in focus in Stock Market Today and on Univest.
Gufic Biosciences Share Price was trading at Rs 448.45 as of 02 September 2026 at 12:48 PM IST, after rising Rs 28 or 6.66% from the previous close of Rs 420.45. During the move, the stock touched Rs 453, which is its fresh 52-week high, while market capitalisation stood at Rs 4,162.23 crore. The latest Gufic Biosciences Share Price action matters because it places the stock in the day’s 52 Week High Stocks list and gives traders a fresh yearly high to track on Univest.
Gufic Biosciences Share Price Today: Price Action Analysis
The latest Gufic Biosciences Stock News confirms the price event, but it does not establish a company-specific catalyst. What can be verified is the day’s range, the gap from the previous close, and the fact that the price reached a one-year high during intraday trade. That makes Gufic Biosciences Share Price a current search focus for readers looking for Gufic Biosciences Share Price Today, Gufic Biosciences News Today and Gufic Biosciences Share Price Live. Univest continues to track the stock with a neutral lens.
| Metric | Value |
|---|---|
| Current Price | Rs 448.45 |
| Previous Close | Rs 420.45 |
| Today's Move | +Rs 28 (+6.66%) |
| Open | Rs 425.05 |
| High | Rs 453 |
| Low | Rs 419 |
| Turnover | Rs 0.9 crore |
| Market Capitalisation | Rs 4,162.23 crore |
Gufic Biosciences Ltd. (GUFICBIO) traded at Rs 448.45 versus the previous close of Rs 420.45, a rise of 6.66%. The stock opened at Rs 425.05, reached a high of Rs 453 and touched a low of Rs 419.
Gufic Biosciences Share Price opened at Rs 425.05, traded between Rs 419 and Rs 453, and last stood at Rs 448.45. That places it Rs 28 above the previous close of Rs 420.45. The stock touched Rs 453 during the move, which is the fresh 52-week peak, and the breakout over the previous 52-week high is 0.00% because the two figures are the same. Turnover stood at Rs 0.9 crore.
For readers tracking Gufic Biosciences Share Price Today, the key facts are straightforward: the stock was above the previous close, it tested a yearly high, and it finished this phase of trading near the top of the day’s range. That is the core Gufic Biosciences Share Price update visible in the market data, and it explains why the name is appearing in Gufic Biosciences Share News and Gufic Biosciences Stock News searches.
Gufic Biosciences Ltd. (GUFICBIO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,162.23 crore |
| P/E Ratio | 57.4x |
| P/B Ratio | 6.14x |
| ROE | 10.14% |
| ROCE | 12.56% |
| EPS | Rs 7.33 |
| Book Value Per Share | Rs 68.53 |
| Dividend Yield | 0.02% |
Gufic Biosciences Ltd. (GUFICBIO) fundamental metrics show P/E 57.4x, P/B 6.14x, ROE 10.14%, ROCE 12.56%. These figures provide context only and are not a buy or sell signal.
Gufic Biosciences Ltd. has a market capitalisation of Rs 4162.23 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 57.4x, P/B at 6.14x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.14% and ROCE of 12.56%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.33, book value per share of Rs 68.53, dividend yield of 0.02%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.13x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 57.4x |
| Benchmark Median P/E | 31.13x |
| Benchmark Average P/E | 48.06x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 6.14x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 10.14% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 12.56% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 4,162.23 crore |
| Benchmark Median Market Cap | Rs 698.8 crore |
Gufic Biosciences Ltd. (GUFICBIO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Gufic Biosciences Ltd. (GUFICBIO) has a P/E ratio of 57.4x, which is above the benchmark median of 31.13x, a difference of +84.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Gufic Biosciences Ltd. (GUFICBIO) has a ROE of 10.14%, which is below the benchmark median of 11.81%, a difference of -14.14%. Gufic Biosciences Ltd. (GUFICBIO) has a ROCE of 12.56%, which is below the benchmark median of 13.65%, a difference of -7.99%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| RPG Life Sciences Ltd. | RPGLIFE | 4,335.45 | 37.11 | 6.72 | 20.28 | 26.99 |
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,916.32 | 12.87 | 1.45 | 9.81 | 10.68 |
| Aarti Drugs Ltd. | AARTIDRUGS | 3,768.99 | 20.37 | 2.44 | 12.68 | 13.11 |
| SMS Pharmaceuticals Ltd. | SMSPHARMA | 3,480.11 | 33.57 | 4.27 | 11.91 | 12.55 |
| Kwality Pharmaceuticals Ltd. | KPL | 3,409.41 | 43.37 | 9.86 | 22.67 | 24.01 |
Gufic Biosciences Ltd. (GUFICBIO) has a P/E ratio of 57.4x compared with the displayed peer median of 33.57x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.14% compares with a peer median of 12.68% across the companies shown in the table. ROCE stood at 12.56% versus the displayed peer median of 13.11%, providing a capital-efficiency comparison. Gufic Biosciences Ltd. (GUFICBIO) has a market capitalisation of Rs 4,162.23 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Gufic Biosciences
- Gufic Biosciences Share Price touched a fresh 52-week high of Rs 453 during intraday trade.
- The stock was last trading at Rs 448.45, up Rs 28 or 6.66% from the previous close.
- Market capitalisation stood at Rs 4,162.23 crore during the move.
- P/E of 57.4 and P/B of 6.14 are above the sector benchmark medians.
- ROE of 10.14% and ROCE of 12.56% sit below the same-industry benchmark medians.
About Gufic Biosciences
Gufic Biosciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Gufic Biosciences Share Price is therefore being tracked within a regulated healthcare and pharmaceutical business backdrop, where investors often compare valuation, returns and reported financial results. The latest Gufic Biosciences Company News and Gufic Biosciences Stock News keep the name visible on Univest as the market processes the fresh 52-week high event.
Frequently Asked Questions
What is Gufic Biosciences Share Price today?
Ans. Gufic Biosciences Share Price was Rs 448.45 at 12:48 PM IST, up 6.66% from the previous close of Rs 420.45. During the move, the stock touched a fresh 52-week high of Rs 453.
Why did Gufic Biosciences touch a fresh 52-week high?
Ans. The latest market data confirms that Gufic Biosciences Share Price touched Rs 453, a fresh 52-week high. The data confirms the price event but does not establish a company-specific catalyst for the move.
What was the day’s range in Gufic Biosciences Share Price?
Ans. Gufic Biosciences Share Price moved between Rs 419 and Rs 453 during the latest trade window. It opened at Rs 425.05 and last stood at Rs 448.45, near the higher end of the day’s range.
What is the market capitalisation of Gufic Biosciences?
Ans. Gufic Biosciences has a market capitalisation of Rs 4,162.23 crore. That places Gufic Biosciences Share Price above the sector benchmark median market cap and below the sector benchmark average in the same-industry set.
How expensive is Gufic Biosciences Share Price on valuation?
Ans. Gufic Biosciences Share Price carries a P/E of 57.4 and a P/B of 6.14. Both are above the sector benchmark medians of 31.13 and 2.87, respectively, which makes the valuation richer than the median peer reading.
What do ROE and ROCE show for Gufic Biosciences?
Ans. ROE is 10.14% and ROCE is 12.56%. Both sit below the same-industry benchmark medians, so Gufic Biosciences Share Price is backed by returns that trail the central benchmark levels in the sector snapshot.
How does Gufic Biosciences compare with peers?
Ans. Gufic Biosciences Share Price has a market cap of Rs 4,162.23 crore, close to RPG Life Sciences and above Unichem, Aarti Drugs, SMS Pharmaceuticals and Kwality Pharmaceuticals. Its P/E is also higher than several peers.
What should investors monitor next in Gufic Biosciences Share Price?
Ans. Investors can monitor whether Gufic Biosciences Share Price stays above the fresh 52-week high zone, how turnover evolves, and whether the company’s reported revenue and profit trend continues to support the latest valuation profile.
Track Gufic Biosciences Share Price on Univest
Use Gufic Biosciences Ltd. (GUFICBIO) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Users can track Gufic Biosciences Share Price on Univest for live share price updates, 52-week high levels, market cap, valuation ratios, financial results, sector comparison and other stock insights. Univest also helps readers follow Gufic Biosciences Share Price Today, Gufic Biosciences Latest News and Gufic Biosciences Share Price Live in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Recent Articles

Suditi Industries (SUDTIND-B) Share Price Falls 9.61% to Rs 63.05
2 September 2026

Zim Laboratories Ltd. (ZIMLAB): Zim Laboratories Share Price Rises 11.31% Today
2 September 2026

Anant Raj (ANANTRAJ) Share Price Fall Streak Extends to Second Straight Session
2 September 2026

Nifty 50 Today: Midday Breadth Weak; Coal India Leads
2 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Suditi Industries (SUDTIND-B) Share Price Falls 9.61% to Rs 63.05
Zim Laboratories Ltd. (ZIMLAB): Zim Laboratories Share Price Rises 11.31% Today
Anant Raj (ANANTRAJ) Share Price Fall Streak Extends to Second Straight Session
Nifty 50 Today: Midday Breadth Weak; Coal India Leads
CRISIL (CRISIL) Share Price Falls 2.49% Today to Rs 4,714.35

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





